A Wait and Watch Approach
All sectors, including the pharmaceutical and supply chain industry, are eagerly waiting the implementation of the Goods and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Cover Story
GST and its impact on pharma
Dr Milind Antani, Legal & Tax Counseling Worldwide, Nishith Desai Associates and Ashish Sodhani, Member, International Tax…
GST: The road ahead
Pratik Jain, Partner — Tax, KPMG India shares insights on the way forward after GST implementation
Biotech Special
The last few years have been painful for India’s biotech sector but many companies have turned adversity into opportunity. Express…
Panacea Biotec: A Turnaround Story
After three consecutive years of negative EBITDA, Panacea Biotec looks set to script a successful revival. Dr Rajesh Jain, Joint…
Fermenta Biotech Limited: Tough gets going
Since the past few years, lack of funding, distrustful investors, and weak global economic conditions have made survival a tall…
Evolva Biotech: Evolving Spirit
Providing innovative, high value, sustainable ingredients, in particular for the health, wellness and nutrition segment, Evolva…
‘I expect a number of IPOs in India and capital inflow for novel ideas’
The 15th edition of Bangalore INDIA BIO 2015 will focus on showcasing to the world the strides taken by Indian companies in the…
Pharma Education: For The Industry, By The Industry
Pharma companies starting their own pharma courses or training institutes to update the curriculum and improve pharma education in…
Dr Bhagwan Dass Miglani: A hospital pharmacist’s progress
On the occasion of this year’s 66th Indian Pharmaceutical Congress, Dr Bhagwan Dass Miglani, Founder Secretary of the Indian…
‘66th IPC will address issues in depth and try to evolve strategies’
Ravi Udaybhaskar, Chairman -Organising Committee and Secretary General, All India Drugs Control Officers Confederation shares the…
Forecast 2015
As 2014 draws to a close, Express Pharma presents some hopes and predictions from thought leaders as they gaze into their crystal…
A Pricey Issue
As part of the ongoing revision of the National List of Essential Medicines (NLEM) 2011, the National Pharma Pricing Authority…
Celebrating 20 Years
1994-2014 Express Pharma Pulse to Express Pharma
As we mark Express Pharma’s 20th anniversary, experts retrospect on some of the…
India on the brink of an opportunity
On Express Pharma’s 20th Anniversary, Ranjana Smetacek, Director General, Organisation of Pharmaceutical Producers of India (OPPI)…
The biotechnology environment
The recent changes in the Government seems to have excited the industry but the real test will be to see if the enthusiasm…
Forging India’s bioeconomy
Without the support of its government, the Indian biotech industry may not be able to achieve its high potential, say James…
Wake up call for Indian pharma
Unless Indian pharma companies wake up to the new “patent challenge” regime, they could “miss the bus”, opines Dr Gopakumar G…
Rising Stars
In the run up to our 20th Anniversary, we try to spot the next crop of winners in India's life sciences universe. In this issue,…
Leap into the future
As newer therapies for cancer hit the market, there's a silent churn going on as diagnostic companies prepare for the future by…